Laia is Investment Manager at Ship2B Ventures, an early stage impact venture capital firm that invests in new technologies aiming at improving the quality of life of patients and the society. She holds a PhD in Tumor Immunology by LMU University and an Executive MBA by IESE Business School, and has first-hand experience as an entrepreneur leading a Biotech company. Laia has also supported several life-science companies to accelerate their growth and define their fundraising strategy as part of EIT Health, a European-wide accelerator.